HomeREGULATORY
REGULATORY

Opdivo Earns Orphan Status for Malignant Pleural Mesothelioma
(Dec.4.2017)

The Ministry of Health, Labor and Welfare (MHLW) on December 1 granted orphan drug designation for Ono Pharmaceutical’s anti-PD-1 antibody Opdivo (nivolumab) for the treatment of malignant pleural mesothelioma, which affects an estimated 2,000 people in Japan ...
(LOG IN FOR FULL STORY)

News Calendar